The U.S. Food and Drug Administration (FDA) announced that Aurobindo Pharma USA is recalling lots of blood pressure medication due to high levels of nitrosamine.

The New Jersey-based company initiated a recall of two lots of Quinapril and Hydrochlorothiazide in 20 milligrams and 12.5 milligram tablets due to the presence of the chemical, which is associated with a higher risk of cancer. The tablets are used to treat high blood pressure.

“Nitrosamines are common in water and foods, including cured and grilled meats, dairy products, and vegetables. Everyone is exposed to some level of nitrosamines,” according to the FDA. “These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.”

But the FDA alert does not say to stop taking the medication.

“Patients should contact their doctor or health care provider about whether to continue taking their medication, or whether to consider an alternative treatment prior to returning their medication,” it said, adding, “To date, Aurobindo Pharma USA, Inc. has not received any reports of adverse events related to this recall.”

Other Recent Recalls

Clorox is recalling its popular Pine-Sol cleaning product in connection to a bacteria exposure risk, according to the U.S. Consumer Product Safety Commission (CPSC).

The agency said that consumers should “immediately stop” using some Pine-Sol products due to them having the bacteria Pseudomonas aeruginosa and other types of bacteria.

“The recalled products may contain bacteria, including Pseudomonas aeruginosa, an environmental organism found widely in soil and water,” said the agency. “People with weakened immune systems or external medical devices who are exposed to Pseudomonas aeruginosa face a risk of serious infection that may require medical treatment.”

“The bacteria can enter the body if inhaled, through the eyes, or through a break in the skin. People with healthy immune systems are usually not affected by the bacteria,” it said.

Unilever United States this week a voluntary recall of several brands of dry shampoo aerosol products because of “potentially elevated levels” of benzene, a  carcinogen.

According to a company announcement that was issued via the FDA’s website, brands that are subject to the recall include Dove, Nexxus, Suave, TIGI (Rockaholic and Bed Head), and TRESemmé. They were made before October 2021 and have been distributed across the United States, the alert said.

Meanwhile, the FDA said earlier this month on its website that bottles of drugs designed to lower blood pressure down contained medication meant for blood clots and strokes, causing a recall of each.

Jack Phillips

Breaking News Reporter


Jack Phillips is a breaking news reporter at The Epoch Times based in New York.

You Might Like
Learn more about RevenueStripe...